US 8569337
Tri-cyclic pyrazolopyridine kinase inhibitors
granted A61KA61K31/496A61K31/506
Quick answer
US patent 8569337 (Tri-cyclic pyrazolopyridine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 43
- CPC classes
- A61K, A61K31/496, A61K31/506, A61P, A61P1/00